(Q40025054)

16 September 2017

title

Development of peptide-targeted lipoplexes to CXCR4-expressing rat glioma cells and rat proliferating endothelial cells (English)

1 reference

16 September 2017

0 references

3

Hirokazu Tamamura

1 reference

16 September 2017

Wouter H P Driessen

1

1 reference

16 September 2017

Nobutaka Fujii

series ordinal

2

1 reference

16 September 2017

Sean M Sullivan

series ordinal

4

1 reference

16 September 2017

publication date

15 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

16

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

516-524

1 reference

Improved DNA: liposome complexes for increased systemic delivery and gene expression

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Cationic lipid-based delivery system for systemic cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Systemic gene delivery expands the repertoire of effective antiangiogenic agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Targeting of polyplexes: toward synthetic virus vector systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Lipid carrier systems for targeted drug and gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Non-viral gene therapy: polycation-mediated DNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Receptor-mediated peptide transport through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Tumor regression by targeted gene delivery to the neovasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

An address system in the vasculature of normal tissues and tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Peptide-mediated gene transfer of cationic lipid/plasmid DNA complexes to endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Enhancement of the T140-based pharmacophores leads to the development of more potent and bio-stable CXCR4 antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Synthesis of potent CXCR4 inhibitors possessing low cytotoxicity and improved biostability based on T140 derivatives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Synthesis of von Willebrand factor by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Receptor targeting of adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300388

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300388

1 reference

16 September 2017

1 reference